Rapid-eye-movement sleep in jittery infants

Area of Science:

• Neuroscience
• Developmental Pediatrics
• Pharmacology

Background:

• Neonatal jitteriness (JT) pathogenesis is unknown, but may relate to maternal medication and withdrawal.
• Behavioral teratology, focusing on environmental and chemical influences on fetal brain development, is a relevant concept.
• Rapid-eye-movement (REM) sleep is proposed as a key area for studying behavioral teratology.

Purpose of the Study:

• To investigate neurophysiological alterations in infants with neonatal jitteriness (JT).
• To examine the role of REM sleep parameters in infants experiencing JT.
• To explore potential links between maternal medication and JT through sleep analysis.

Main Methods:

• Sleep records were analyzed for six jittery infants and age-matched controls.
• Three jittery infants had mothers who took medication during pregnancy; three did not.
• REM sleep parameters, including tonic inhibition index (TII) and phasic chin muscle activity (PCMA), were compared.

Main Results:

• Jittery infants exhibited significantly higher tonic inhibition index (TII) during REM sleep compared to controls.
• TII, reflecting shortened PCMA, was elevated regardless of maternal medication status.
• No other consistent differences in REM sleep parameters were observed between jittery infants and controls.

Conclusions:

• Elevated TII in neonatal jitteriness may be linked to the blockade release of fetal brain dopamine D2 receptors.
• Continuous monitoring of jittery infants is recommended from a "behavioral teratology" perspective.
• Abnormal TII elevation persisted beyond the resolution of clinical jitteriness, suggesting long-term neurophysiological changes.